1. ScholarBank@NUS

Ravindran Kanesvaran

rp28125

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Ravindran Kanesvaran
Main Affiliation
 
Faculty
 
Email
gmskara@nus.edu.sg
 

Publications

Results 1-13 of 13 (Search time: 0.014 seconds).

Issue DateTitleAuthor(s)
11-Feb-2019(68)Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomyTan, Janice SH; Goh, Charles XY ; Kohl, Yen Sin; Li, Youquan ; Tuan, Jeffrey KL ; Chua, Eu Tiong ; Tan, Terence WK ; Wang, Michael LC ; Lee, Lui Shiong ; Tay, Kae Jack ; Kanesvaran, Ravindran ; Toh, Chee Keong ; Tong, Aaron KT ; Lam, Winnie WC ; Chua, Melvin LK
22020Assessing mentoring: A scoping review of mentoring assessment tools in internal medicine between 1990 and 2019Ng, Y.X.; Koh, Z.Y.K.; Yap, H.W.; Tay, K.T.; Tan, X.H.; Ong, Y.T.; Tan, L.H.E.; Chin, A.M.C. ; Toh, Y.P.; Shivananda, S.; Compton, S.; Mason, S.; Kanesvaran, R. ; Krishna, L. 
32015Association of ABCB1 and FLT3 polymorphisms with toxicities and survival in asian patients receiving sunitinib for renal cell carcinomaChu Y.-H.; Li H. ; Tan H.S.; Koh V.; Lai J.; Phyo W.M.; Choudhury Y.; Kanesvaran R. ; Chau N.M.; Toh C.K.; Ng Q.S.; Tan P.H.; Chowbay B. ; Tan M.-H. 
42020Combined novice, near-peer, e-mentoring palliative medicine program: A mixed method study in SingaporeKrishna, L.; Tay, K.T.; Yap, H.W.; Koh, Z.Y.K.; Ng, Y.X. ; Ong, Y.T.; Shivananda, S.; Compton, S.; Mason, S.; Kanesvaran, R. ; Toh, Y.P.
52017Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicityChoudhury, Y.; Toh, Y.C. ; Xing, J.; Qu, Y.; Poh, J.; Li, H.; Tan, H.S.; Kanesvaran, R. ; Yu, H.; Tan, M.-H.
62018Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): Prospective cohort study protocolTeo, I ; Singh, R; Malhotra, C ; Ozdemir, S ; Dent, R.A ; Kumarakulasinghe, N.B; Yeo, W.L; Cheung, Y.B ; Malhotra, R ; Kanesvaran, R ; Yee, A.C.P ; Chan, N ; Wu, H.Y; Chin, S.M; Allyn, H.Y.M; Yang, G.M ; Neo, P.S.H ; Nadkarni, N.V ; Harding, R; Finkelstein, E.A 
72020HPLC-MS/MS coupled with equilibrium dialysis method for quantification of free drug concentration of pazopanib in plasmaToh, Y.L.; Pang, Y.Y.; Shwe, Maung; Kanesvaran, R. ; Toh, C.K.; Chan, A.; Ho, H.K. 
82016Identification of comprehensive geriatric assessment based risk factors for malnutrition in elderly Asian cancer patientsTan T.; Ong W.S.; Rajasekaran T.; Koo K.N. ; Chan L.L.; Poon D. ; Chowdhury A.R.; Krishna L. ; Kanesvaran R. 
92015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. 
103-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
1124-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
122017Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicityChoudhury, Y; Toh, Y.C ; Xing, J; Qu, Y; Poh, J; Huan, L; Tan, H.S; Kanesvaran, R ; Yu, H ; Tan, M.-H 
132018Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: A systematic reviewCheng, K.K.-F. ; Lim, E.Y.-T. ; Kanesvaran, R.